Zobrazeno 1 - 10
of 165
pro vyhledávání: '"Robbert G M Bredius"'
Autor:
Jaak M Vossen, Harry F L Guiot, Arjan C Lankester, Ann C T M Vossen, Robbert G M Bredius, Ron Wolterbeek, Hanny D J Bakker, Peter J Heidt
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e105706 (2014)
The hypothesis that elimination of facultative and strict anaerobic microorganisms from the gastro-intestinal tract by antimicrobial drugs in the period of time around allogeneic bone marrow transplantation (BMT) prevents acute graft-versus-host dise
Externí odkaz:
https://doaj.org/article/f7bb54cc40254fff8d56aa9a6e4d554d
Autor:
Yenny Djuardi, Heri Wibowo, Taniawati Supali, Iwan Ariawan, Robbert G M Bredius, Maria Yazdanbakhsh, Laura C Rodrigues, Erliyani Sartono
Publikováno v:
PLoS ONE, Vol 4, Iss 11, p e7711 (2009)
Exposure to environmental factors during fetal life and infancy is thought to play an important role in the early development of innate and adaptive immunity. The immunological relationship between mother and infant and the effect that environmental
Externí odkaz:
https://doaj.org/article/3c6dea1d2ad34824abd174a41a47d2c6
Autor:
Khalil Ben Hassine, Tiago Nava, Yves Théoret, Christa E. Nath, Youssef Daali, Nastya Kassir, Victor Lewis, Robbert G. M. Bredius, Peter J. Shaw, Henrique Bittencourt, Maja Krajinovic, Chakradhara Rao Satyanarayana Uppugunduri, Marc Ansari
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 9, Pp 1043-1056 (2021)
Abstract Busulfan (Bu) is a common component of conditioning regimens before hematopoietic stem cell transplantation (HSCT) and is known for high interpatient pharmacokinetic (PK) variability. This study aimed to develop and externally validate a mul
Externí odkaz:
https://doaj.org/article/4a2a660863bf4f659cde9d7b20f139cd
Autor:
M. Y. Eileen C. van der Stoep, Dagmar Berghuis, Robbert G. M. Bredius, Emilie P. Buddingh, Alexander B. Mohseny, Frans J. W. Smiers, Henk-Jan Guchelaar, Arjan C. Lankester, Juliette Zwaveling
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Treosulfan is increasingly used as myeloablative agent in conditioning regimen prior to allogeneic hematopoietic stem cell transplantation (HSCT). In our pediatric HSCT program, myalgia was regularly observed after treosulfan-based condition
Externí odkaz:
https://doaj.org/article/32df6957af434a298b3c729660b8644e
Autor:
M. Y. Eileen C. van der Stoep, Lisa V. E. Oostenbrink, Robbert G. M. Bredius, Dirk Jan A. R. Moes, Henk-Jan Guchelaar, Juliette Zwaveling, Arjan C. Lankester
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Allogeneic hematopoietic stem cell transplantation (HSCT) is an established curative treatment that has significantly improved clinical outcome of pediatric patients with malignant and non-malignant disorders. This is partly because of the use of saf
Externí odkaz:
https://doaj.org/article/aab977d8e9ee488c9aa14ced7a54e661
Publikováno v:
International Journal of Neonatal Screening, Vol 7, Iss 4, p 74 (2021)
Newborn screening (NBS) programs continue to expand due to innovations in both test methods and treatment options. Since the introduction of the T-cell receptor excision circle (TREC) assay 15 years ago, many countries have adopted screening for seve
Externí odkaz:
https://doaj.org/article/794faf1d432e4bc4a280e08927db2b34
Autor:
M. Elske van den Akker-van Marle, Maartje Blom, Mirjam van der Burg, Robbert G. M. Bredius, Catharina P. B. Van der Ploeg
Publikováno v:
International Journal of Neonatal Screening, Vol 7, Iss 3, p 60 (2021)
Although several countries have adopted severe combined immunodeficiency (SCID) into their newborn screening (NBS) program, other countries are still in the decision process of adding this disorder in their program and finding the appropriate screeni
Externí odkaz:
https://doaj.org/article/58c28908b47746d4843102b2319ea323
Autor:
Federica R. Achini-Gutzwiller, Cornelia M. Jol-van der Zijde, Anja M. Jansen-Hoogendijk, Arjan C. Lankester, Robbert G. M. Bredius, Maarten J. D. van Tol, Dirk Jan A. R. Moes, Marco W. Schilham
Publikováno v:
Therapeutic Drug Monitoring. 45:79-86
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91b4550e643339ae76e1700351ec5a1d
https://doi.org/10.1097/ftd.0000000000001037
https://doi.org/10.1097/ftd.0000000000001037
Autor:
Rick, Admiraal, Stefan, Nierkens, Marc B, Bierings, Robbert G M, Bredius, Ineke, van Vliet, Yilin, Jiang, Marta, Lopez-Yurda, A Birgitta, Versluijs, C Michel, Zwaan, Caroline A, Lindemans, Jaap Jan, Boelens
Publikováno v:
The Lancet Haematology, 9(2), e111-e120. Lancet Publishing Group
Background: Anti-thymocyte globulin, which is used in the conditioning of haematopoietic stem-cell transplantation (HSCT) to prevent graft-versus-host disease (GVHD) and graft failure, has highly variable pharmacokinetics. Overexposure to anti-thymoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f41c9f6d5007004ab5ec065beb7dfc0d
https://doi.org/10.1016/s2352-3026(21)00375-6
https://doi.org/10.1016/s2352-3026(21)00375-6
Autor:
Sanne Oegema, Stefanie S. V. Henriet, Koen J. van Aerde, Robbert G. M. Bredius, Dagmar Berghuis
Publikováno v:
Journal of Clinical Immunology, 42, 8, pp. 1608-1610
Journal of Clinical Immunology, 42, 1608-1610
Journal of Clinical Immunology, 42, 1608-1610
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63003f257d602a697d0d29aecf63b3d
https://doi.org/10.1007/s10875-022-01336-z
https://doi.org/10.1007/s10875-022-01336-z